The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Levetiracetam Actavis Group 100 mg/ml oral solution

Actavis Group hfEU/1/11/738/001-003

Main Information

Trade NameLevetiracetam Actavis Group 100 mg/ml oral solution
Active SubstancesLevetiracetam
Dosage FormOral solution
Licence HolderActavis Group hf
Licence NumberEU/1/11/738/001-003

Group Information

ATC CodeN03AX Other antiepileptics
N03AX14 levetiracetam


License statusAuthorised
Licence Issued
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website

Generics Information

Interchangeable List CodeIC0119-171-019
Interchangeable List DocumentPDF of Interchangeable List
« Back